2-methoxyestradiol has been researched along with Leiomyoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Borahay, MA; Bujalowski, PJ; Enazy, SA; Kilic, G; Kirschen, GW; Motamedi, M; Oberhauser, AF; Rytting, E; Saada, J; Salama, SA; Shah, M; Vincent, K; Yang, J | 1 |
| Borahay, MA; Kilic, GS; Motamedi, M; Ozpolat, B; Salama, SA; Tekedereli, I; Vincent, KL | 1 |
| Borahay, MA; Botting, S; Diaz-Arrastia, CR; Hamed, AA; Kamel, MW; Kilic, GS; Saeed, M; Salama, SA; Salih, SM; Williams, MY | 1 |
| Diaz-Arrastia, CR; Kamel, MW; Kilic, GS; Salama, SA | 1 |
| Ali, H; Kilic, G; Motamedi, M; Rytting, E; Vincent, K | 1 |
| Al-Hendy, A; Dubey, RK; Nasr, AB; Salama, SA | 1 |
6 other study(ies) available for 2-methoxyestradiol and Leiomyoma
| Article | Year |
|---|---|
PEGylated Polymeric Nanoparticles Loaded with 2-Methoxyestradiol for the Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Topics: 2-Methoxyestradiol; Animals; Estrogens; Female; Heterografts; Humans; Leiomyoma; Mercaptoethanol; Mice; Mice, Inbred NOD; Nanoparticles; Polyethylene Glycols; Polymers; Progesterone | 2023 |
Liposomal 2-Methoxyestradiol Nanoparticles for Treatment of Uterine Leiomyoma in a Patient-Derived Xenograft Mouse Model.
Topics: 2-Methoxyestradiol; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Proliferation; Drug Compounding; Female; Humans; Ki-67 Antigen; Leiomyoma; Liposomes; Mice, Inbred NOD; Mice, SCID; Nanoparticles; Tumor Burden; Uterine Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells.
Topics: 2-Methoxyestradiol; Apoptosis; Aromatase; Catechol O-Methyltransferase; Estradiol; Estrogen Receptor alpha; Female; Humans; Leiomyoma; Microtubules; Neovascularization, Pathologic; Receptors, Progesterone; Receptors, Steroid; Signal Transduction; Tumor Necrosis Factor-alpha; Uterine Neoplasms | 2009 |
2-Methoxyestradiol causes functional repression of transforming growth factor β3 signaling by ameliorating Smad and non-Smad signaling pathways in immortalized uterine fibroid cells.
Topics: 2-Methoxyestradiol; Cell Line, Transformed; Cell Nucleus; Down-Regulation; Drug Evaluation, Preclinical; Estradiol; Female; Fibrosis; Humans; Leiomyoma; Phosphorylation; Protein Binding; Protein Transport; Signal Transduction; Smad Proteins; Transforming Growth Factor beta3; Tubulin | 2012 |
Nanomedicine for uterine leiomyoma therapy.
Topics: 2-Methoxyestradiol; Calorimetry, Differential Scanning; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Carriers; Drug Stability; Drug Storage; Estradiol; Female; Humans; Lactic Acid; Leiomyoma; Nanomedicine; Nanoparticles; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Time Factors; Tubulin Modulators; Uterine Neoplasms; X-Ray Diffraction | 2013 |
Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids.
Topics: 2-Methoxyestradiol; Animals; Antimitotic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Collagen; Estradiol; Estrogens; Female; Humans; Leiomyoma; Rats; Uterine Neoplasms | 2006 |